REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

por Martin-Broto, Javier, Valverde, Claudia, Hindi, Nadia, Vincenzi, Bruno, Martinez-Trufero, Javier, Grignani, Giovanni, Italiano, Antoine, Lavernia, Javier, Vallejo, Ana, Tos, Paolo Dei, Le Loarer, Francois, Gonzalez-Campora, Ricardo, Ramos, Rafael, Hernández-Jover, Diana, Gutierrez, Antonio, Serrano, Cesar, Monteagudo, Maria, Letón, Rocio, Robledo, Mercedes, Moura, David S., Martin-Ruiz, Marta, López-Guerrero, Jose A., Cruz, Julia, Fernandez-Serra, Antonio, Blay, Jean-Yves, Fumagalli, Elena, Martinez-Marin, Virginia
Publicado 2023